StockSelector.com
  Research, Select, & Monitor Monday, July 23, 2018 6:00:51 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Bristol-Myers Squibb Co.$56.71$.17.30%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Bristol-Myers Squibb Co. has an overall rank of 1102 out of 7039 stocks based on 18 positive rankings and 6 negative rankings.

Positive Rankings
Beat Whisper
According to EarningsWhispers.com, Bristol-Myers Squibb Co. beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Top Intrinsic Values
Bristol-Myers Squibb Co. rank is 291
Positive Guidance
Within the past 90 days Bristol-Myers Squibb Co. has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Low vPut/Call
Bristol-Myers Squibb Co. has a low Put/Call ratio of 0.17 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Bristol-Myers Squibb Co. is ranked 329.
PEGValue
Bristol-Myers Squibb Co. has a PEG Value of $77.93. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 37.43% in the next year. Among companies with a PEG Value above the current stock price, Bristol-Myers Squibb Co. is ranked 426.
Highest Cash Growth
Bristol-Myers Squibb Co. rank is 444
Top Industry Values
Bristol-Myers Squibb Co. rank is 547
SSValue
The StockSelector Value for Bristol-Myers Squibb Co. is $87.73. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Bristol-Myers Squibb Co. is ranked 645.
Estimated EPS Growth
Bristol-Myers Squibb Co. rank is 959
Historic EPS Growth
Bristol-Myers Squibb Co. rank is 1025
Low Put/Call
Bristol-Myers Squibb Co. has a low Put/Call ratio of 0.63 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Bristol-Myers Squibb Co. is ranked 1230.
Up EPS Surprise
Bristol-Myers Squibb Co. beat the consensus earnings estimate when it last reported quarterly earnings.
Estimated Revenue Growth
Bristol-Myers Squibb Co. rank is 1694
Highest ROE
Bristol-Myers Squibb Co. rank is 1929
10 Day Gain
Bristol-Myers Squibb Co. rank is 1950
Highest ROA
Bristol-Myers Squibb Co. rank is 1989
Historic Revenue Growth
Bristol-Myers Squibb Co. rank is 2236
Highest Net Margin
Bristol-Myers Squibb Co. rank is 2581
Negative Rankings
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Bristol-Myers Squibb Co. is ranked 290.
Price-to-Book
Bristol-Myers Squibb Co. rank is 592
Overbought Stochastics
Bristol-Myers Squibb Co. rank is 786
90 Day Loss
Bristol-Myers Squibb Co. rank is 882
Price-to-Sales
Bristol-Myers Squibb Co. rank is 1333
Debt-to-Equity
Bristol-Myers Squibb Co. rank is 1747







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.